Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.

Genes and Schizophrenia: From a Festschrift Seminar honoring

recent data have begun to elucidate the genetic architecture of schizophrenia, as well as provide new insights into the relationships of specific genetic factors across diagnostic boundaries, with specific symptom domains, and in the prediction of antipsychotic treatment response. not surprisingly, work conducted at the Maryland psychiatric research center (Mprc), led by dr William carpenter, h...

Progress in the study of negative symptoms.

A selective review of the negative symptoms of schizophrenia is an appropriate article to result from the festschrift honoring William T. Carpenter Jr, as he has made substantial contributions in this area. This review assesses progress in 3 areas in which he has been an important investigator: the distinction between primary vs secondary negative symptoms; the appropriate design for treatment ...

Celebrating the work of William T. Carpenter Jr.

The NIMH-MATRICS consensus statement on negative symptoms.

Brian Kirkpatrick, Wayne S. Fenton, William T. Carpenter, Jr., and Stephen R. Marder Department of Psychiatry and Health Behavior, Medical College of Georgia; Division of Adult Translational Research and Development, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services; MarylandPsychiatricResearchCenter,DepartmentofPsychiatry, University of...

D-Cycloserine: A Novel Pharmacological Agent for Treating Anxiety Spectrum Disorders

D-Cycloserine: A Novel Pharmacological Agent for Treating Anxiety Spectrum Disorders Katherine Martin, M.D. Melanie Sisti, M.D. 12 A Novel Project in Student Education Snehal Bhatt, M.D. Heather Grigo, M.D. Anthony Tobia, M.D. Barbara Palmeri, M.D. 6 clickable The following is an interview with William Carpenter, Jr., M.D., on “Psychotic Disorders and DSM-V,” conducted by Maju Koola, M.D. Dr. C...